Sign in to view content

Intravitreal Methotrexate for the Treatment and Prevention of Proliferative Vitreoretinopathy in Pediatric Patients

Philip J. Ferrone, MD, FASRS

Video
Published 2025

Related

Intravitreal Infliximab for the Treatment of Proliferative Vitreoretinopathy Associated with Rhegmatogenous Retinal Detachment: The Phase II FIXER Trial
Ayman Elnahry, MD, PhD
Annual Meeting Talks
2023
Primary Retinal Detachment Repair in Eyes Deemed High Risk for Proliferative Vitreoretinopathy: Surgical Outcomes in 605 Eyes
M. Ali Khan, MD, FACS, FASRS
Annual Meeting Talks
2025
Phase 3 GUARD Trial of ADX-2191 (Methotrexate for Intravitreal Administration) to Prevent Proliferative Vitreoretinopathy and Other Postoperative Complications
Christina Joy Flaxel, MD
Annual Meeting Talks
2023

Category: Retinal Detachment

See more